AI in life sciences is about more than just technology adoption. It’s about transforming the way life sciences organisations innovate, operate and create value.
From accelerating R&D, innovating across product portfolios, optimising clinical trials to streamlining supply chains, AI can invigorate across multiple facets of the industry.
This global report from KPMG, Intelligent Life Sciences, identifies the attributes of high-performing organisations as well as the critical enablers of AI adoption, including data infrastructure, workforce readiness and governance.
It also defines AI-driven value creation in life sciences, focussing on the ways AI enhances R&D productivity and operations, while also addressing return on investment challenges.
